IMAGE no01.gif

"DJERASSI CLEARLY KNOWS HIS WAY
AROUND LABS AND THE MONEY THAT MAKES
THEM GO... THE SUCCESS OF VIAGRA LENDS
UNINTENTIONAL PRESCIENCE TO THE
NOVEL'S SCIENTIFIC-FISCAL INTRIGUES."
(Publishers Weekly)

"FOR INSIGHT INTO THE GRANTS
APPARATUS, THE BUREAUCRACY OF
SCIENCE, AND THE WAY SCIENTISTS THINK
AND WORK, DJERASSI IS YOUR MAN."
(Kirkus Reviews)

"DJERASSI HAS PROVIDED A KEYHOLE
PERSPECTIVE ON THE PRACTITIONERS OF HIS
FIELD, AND THE RESULT IS ORIGINAL AND
UNEXPECTEDLY ENGROSSING."
(San Francisco Sunday Examiner &
Chronicle)

"DJERASSI'S FIFTH NOVEL NICELY
ANTICIPATES VIAGRA... "NO"IS A JOLLY
GOOD READ, WRITTEN BY SOMEONE WHO
OUGHT TO KNOW WHAT HE IS TALKING
ABOUT."
(New Scientist)

"THE READER [WILL] BE GRIPPED BY THE WELL-RESEARCHED BIOLOGY OF NO AND
THE "JOUISSANCE" DERIVED FROM READING ABOUT THE SCIENCE OF SEX...
EXTREMELY TOPICAL, GIVEN THE CURRENT VIAGRA MANIA"
(Nature)

"THE INTERCALATION OF DISTINCT PLOT ELEMENTS IS MARVELOUSLY PLAYFUL
AND REVEALING."
(The New England Journal of Medicine)

NO

At first glance, most readers would pronounce and interpret the title of this novel as a negative expletive. But all-capitalized-each letter pronounced separately-NO is also the chemical formula of the simple, diatomic molecule, nitric oxide, which in 1992 the multidisciplinary journal Science named "Molecule of the Year" under the cover title "Just say NO." As will become clear, both meanings are relevant to this fourth volume in my science-in-fiction tetralogy.

In contrast to science fiction, the much rarer genre of science-in-fiction is based in real, or at least plausible, science. Except for some minor predating in chronology (to fit my plot), no significant aspects of the newly discovered biological properties of NO are made up. Nor, for that matter, is the conduct of the various scientific protagonists, entrepreneurs, and lawyers. They may not exist, but their manners and practices are right on the mark.

As a chemist, I could not resist the temptation to consider, in these days of rampant chemophobia the recent extraordinary discovery that nitric oxide (NO)-an industrial gas and environmental pollutant (the discovery of which was honored by the 1995 Nobel Prize in Chemistry)-does in fact fulfill a singularly complicated and sophisticated function in the human body, where (continuously generated) it serves as a biological messenger, indispensable in a staggering variety of processes, including penile erection. This, in turn, led me to use the therapeutic treatment of male functional impotence as the vehicle for illustrating the role of a biotech company in contemporary biomedical research.

Current investigations on erectile dysfunction center around a device, called MUSE (an acronym for Medicated Urethral System for Erection), the invention of VIVUS, Inc., a California company of the 1990s. The originator of MUSE and founder/chairman of VIVUS, Dr. Virgil Place, has generously provided me with unpublished technical information on the treatment of male impotence which I have woven into my plot. But caveat lector: my description of the fictional MUSA system (Medicated Unit for Sexual Arousal and also the name of the genus to which the banana plant belongs) and especially its incorporation of NONOates (the class of nitric oxide releasers recently reported by the National Cancer Institute) should by no means be read as constituting an endorsement of any treatment for erectile dysfunction.

Since my own scientific contributions in reproductive biology have focused on women rather than men, I could not resist introducing a second biotech development involving ovulation prediction-a current focus of my teaching at Stanford University. The electrochemical approach and the fictitiously named Wizard of Ov described in this novel are based in part on very recent developments of Conception Technology, Inc., in Fort Collins, Colorado. But the same caveat applies here as well: I take no responsibility for any child's paternity or any failure in sex-predetermination based on the use of this novel's Wizard.

The research scientist's culture and mores are tribal. Like most such behavior, scientific tribalism is acquired by example, by apprenticeship via a mentor-disciple relationship, and by intellectual osmosis rather than through textbooks or lectures. Members of the scientific tribe rarely describe their cultural practices, not because they have signed a covenant of secrecy nor because one's own cultural routine is rarely articulated but because research scientists generally are uninterested in dialog with the lay public. In science, professional advancement and recognition depend solely on approbation by one's peers, not on communication with or approval by nonscientific outsiders.

As a long-term insider of this tribe, I am attempting to narrow the ever-widening gulf between the scientific community and the other subcultures of contemporary society-the arts and humanities, the social sciences and, most strikingly, the culture at large-through the medium of science-in-fiction. Until now, my novels focused mostly on the academic world, but in NO, I have moved to another subculture with which contemporary science exists in a sometimes uneasy relationship: industry-more specifically, the small, entrepreneurial, research-driven enterprises sometimes collectively referred to as biotech.

As a founder, former officer and director, and occasional gadfly of several such companies-as well as a university professor-I am intimately familiar with this setting. Furthermore, in contrast to "big" industry, biotech companies of the eighties and nineties are a uniquely American phenomenon born out of academia (much of it right in my own backyard-the San Francisco Bay Area). Because of their intellectual origins in educational institutions, biotech ventures have generated a series of contentious problems, arising from the interaction of profit-driven enterprises with supposedly non-profit institutions and (ideally) disinterested individual scientists. These have caused numerous legal, philosophical, and ethical debates that will continue to influence the conduct of science within the academy, as well as the ways it is disseminated into the economy and culture at large. NO describes some of these behind the thin veil of fiction.

One other issue that I have chosen to highlight here is the scientist's overwhelmingly patriarchal clan culture in which my fictional, and at times not so fictional, characters move. In my fiction, I invariably return to two gender issues: the historic marginalization of women in the male-dominated scientific universe and the attempts of modern women, as well as some men, to change this state of affairs. No wonder most of my female characters are "independent"--a pejorative term to some but the ultimate compliment in my own eyes.

-----------------------------------------------------------------------------------

An excerpt from chapter 16 (in which characters from all earlier novels appear):

"I didn't know you were interested in English antiques, Max."

"My new wife is, so I'm starting to learn."

"Ah yes, your wife. I understand she has one of those MacArthur 'genius' awards. What's it like to live with a genius?"

"So far, great. About the only disadvantage I see is that I'll never get a MacArthur. I don't think they'd give another one to a spouse."

"I know how you must feel, Max," Cantor eyed him craftily. "They don't seem to give them to Nobel recipients either. They must think we're now completely satisfied."

"And are you?" asked Celestine Price, who had listened to their exchange with increasing annoyance.

"You should know," Cantor said somewhat brittlely. "You're living with one." He turned away to address the rest. "The deli promised delivery by twelve. There will be wine, of course... quite passable vintages, if I may say so, from California, naturally, in honor of our corporate sponsor and of Renu, who's flown all the way to Chicago to simplify life for us busy academics." He inclined his head in Renu's direction, ignoring Celestine Price, who had come in from Los Angeles. "Although we should abstain from alcohol until we have completed at least some of our business. In the meantime, there are plenty of non-alcoholic drinks over there," he motioned in the general direction of the kitchen, "soft drinks, juices, mineral water....". His eyes cruised around the table past his four colleagues, to rest, with undisguised disapproval, on the plastic mineral water bottle by Celestine Price's side. At least, he observed, she'd had the courtesy to place it on her notepad, but the fact didn't mollify him sufficiently, especially since she found it necessary to take a sip or two every few minutes. Cantor was old-fashioned enough to object to the current vogue among younger women, notably the "organic" members of that class, who ostentatiously carry their water bottles with them whether they are jogging or going to the opera-like wearing Nikes with a formal dress. In his home, it offended his sense of esthetics and propriety, implying as it did the unavailability of anything but "ordinary" H2O from his kitchen faucet. He'd never forgotten his falling out of sync during a quartet performance when he'd noticed a young female listener taking a swig while he fiddled rapturously. But Celestine Price of all people!

His irritation was fueled by the realization that he had only himself to blame. Chairing the SAB was hardly onerous-this was only the third meeting they'd held in two years, and he'd even persuaded Renu Krishnan to schedule this one in Chicago. "Marletta is practically next door, in Ann Arbor," he'd said at the conclusion of their last meeting in Palo Alto. "And Weiss can fly here in a couple of hours from Newark. Let's meet in my apartment in Chicago. It's properly off-campus-after all we shouldn't conduct non-university business on hallowed academic turf," he'd added with a conspiratorial wink that seemed out of character," and we can all be back in our homes the same evening. That is, everyone but you, Renu. But think of the money SURYA saves by our not flying to the West Coast."

Two excerpts from chapter 18:

"John Maddox, the editor of Nature, once wrote that science is intrinsically bad-mannered."

"Come now, Celly. That's overstating it."

"No, it isn't. Each of us wants to be there first. We push pretty hard to get there and if someone should beat us we break our backs trying to prove him wrong. In my case, especially if it's a him. Of course in science, having others trying to prove us wrong is what keeps us honest. But in the process, we do lust-blood-lust, I think it's called."

"Oh come now, Celly. Are you suggesting that people do science because it's some kind of competition? A contact sport for nerds?"

"It's an unpleasant proposition to defend," sighed Celestine, "but how about this? The evolutionary argument has been made that humans have a mixed allegiance to two contradictory codes of conduct: friendly cooperation within their community, but competition and warfare outside it. We approve of amity, but enmity between states is a necessary condition for human evolution. Maybe that's what made William James ask whether one could find a moral equivalent for war. It seems to me that you'll only have to read 'competition' for 'war' to find yourself in the scientific world, which at the same time pays homage to cooperation. What I'm saying is sad in a way but probably true."

Renu broke the silence. "Are you competing with your husband?"

* * * * *

Celestine reached across the table to pat her hand. "Enough of husbands. Let's talk about us women. I've never asked before, but why didn't you consider an academic career?"

"But I did." Renu's reply was instantaneous. "In contrast to what you told me about your own training, about getting your Ph.D. with a woman professor, I had no women role models. My supervisor in grad school at Stanford was a man. Even my undergraduate research was done with a man, Michael Marletta. And then came my postdoc with Prof Frankenthaler. They all were very supportive and assumed all along that I'd stay in the academic pipeline, but," Renu's tone turned critical, "no one talked about the extreme leakiness of that pipe, especially for women. I know there are exceptions. You're a remarkable one: a tenure-track job in one of the top universities without even a prior postdoc. Now don't take this as a criticism." She leaned forward. "But, in the process, you seem to have accepted all of the male values. Right now, how much leeway do you give your graduate students? Aren't they expected to work on what you tell them to work on? And won't you be tempted to keep the best students just a bit longer, precisely because they are so productive and because that productivity will help you get tenure? And when you do pass that hurdle and get lots of grants, will you be tempted to have an army of two or three dozen pairs of hands like some of the big shots in organic chemistry?" Renu realized her voice was getting loud. She straightened, and tried to calm down. "Even if none of that should apply to you, just think what you said a moment ago about competition."

"And you're so different?" Celestine said coolly. "In your position as president of a high-tech company? In testosterone-soaked Silicon Valley?"


Hardback edition published August 1998 by the University of Georgia Press, Athens, GA 30602
(telephone orders: (USA) 1-800-266-5842; (Internat.) 706-369-6130)
ISBN 0-8203-2032-3

Paperback edition published October 30, 2000 by Penguin Books, New York, NY.
ISBN 0 14 02.9654 9